176 related articles for article (PubMed ID: 1465837)
21. Living-unrelated renal transplantation.
Simforoosh N; Bassiri A; Amiransari B; Gol S
Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
[No Abstract] [Full Text] [Related]
22. HLA-DR matching defined by SSO-typing in heart transplantation.
Poli F; Scalamogna M; Pappalettera M; Mascaretti L; Nocco A; Crespiatico L; Sirchia G
Transplant Proc; 1992 Dec; 24(6):2436-7. PubMed ID: 1465820
[No Abstract] [Full Text] [Related]
23. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
[No Abstract] [Full Text] [Related]
24. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
Middleton D; Martin J; Magee BA; Douglas JF
Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
[No Abstract] [Full Text] [Related]
25. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G
Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
[No Abstract] [Full Text] [Related]
26. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
Velidedeoğlu E; Tokyay R; Haberal M
Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
[No Abstract] [Full Text] [Related]
27. Cold ischemia time and MHC class II matching in renal transplants.
Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
[No Abstract] [Full Text] [Related]
28. Cyclosporine-related hypercoagulability: fact or fiction?
Edwards CM; Morgan JD; Donnelly PK
Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
[No Abstract] [Full Text] [Related]
29. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin S; Dyer PA; Scott PD
Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
[No Abstract] [Full Text] [Related]
30. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
31. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
[TBL] [Abstract][Full Text] [Related]
32. The graft survival curve: ideology and rhetoric.
Guttmann RD
Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
[No Abstract] [Full Text] [Related]
33. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
Berthoux FC; Guerin C; Burgard G; Berthoux P; Alamartine E
Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
[No Abstract] [Full Text] [Related]
34. Kidney transplantation in Slovenia from 1986 through 1991.
Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
[No Abstract] [Full Text] [Related]
35. Is superior graft survival of multiorgan donor kidneys due to better preservation or better organ selection?
Albrecht KH; Rudy T; Niebel W; Eigler FW
Transplant Proc; 1992 Dec; 24(6):2748-9. PubMed ID: 1465925
[No Abstract] [Full Text] [Related]
36. Fully parametric analysis of kidney graft survival.
Vereerstraeten P
Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
[No Abstract] [Full Text] [Related]
37. Patterns of "hidden" humoral allosensitization to HLA-A2 revealed by a simple modification of the standard lymphocytotoxic test.
Bohinjec M; Vidan B
Transplant Proc; 1992 Dec; 24(6):2497-501. PubMed ID: 1465844
[No Abstract] [Full Text] [Related]
38. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
[No Abstract] [Full Text] [Related]
39. Low-dose OKT3 for cadaveric renal transplantation.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
[No Abstract] [Full Text] [Related]
40. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
